Public Research Library
Specialties:
Most Popular Reports:
- Laser Body Sculpting SmartLipo-Trends in Use
- Essure Permanent Birth Control
- Oral Contraceptives Market Evaluation
- Trends and Forecast of Dental Implant Cases
- Avastin and the AVADO Trial Survey
Newest Reports:
NxStage Medical and the Home Hemodialysis Market
A Panel Discussion among Eight Dialysis Clinic Managers and Owners
Study Description and Objectives
Panel Intelligence engaged a set of eight dialysis clinic owners and managers to understand experiences with NxStage Medical’s (NXTM) home hemodialysis system NxStage System One™. Secondary objectives of this study included the following:
§ Estimate current penetration of the NxStage System One™ into the hemodialysis (HD) market, patient types most likely to use the system, and market opportunity.
§ Gauge differences in perceptions of home dialysis units among small community dialysis centers and those affiliated with large firms (i.e., DaVita, Wellbound / Satellite Healthcare, Fresenius).
§ Understand the home dialysis market from the point of view of the large and small clinic owner/managers, especially any perceived threats to patient volumes and risks of adopting the system.
§ Compare the patient experience versus traditional HD patients in terms of number of dialysis treatments per week, medication usage in general, and erythropoietin usage levels.
§ Identify barriers and facilitators to adoption of the System One™ home HD system, especially issues related to cost, risk, support staff needed, and the associated learning curve.
§ Understand impact of managed care on clinic revenues and margins as it pertains to use of home HD.
§ Determine impact of the recent NxStage recall on perceptions of the system among current users and potential adopters.
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
NxStage Medical |
NXTM |
NxStage System One™; PureFlow SL |
|
DaVita, Inc. |
DVA |
None |
|
Fresenius Medical Care |
FMC |
None, limited coverage |
|
Satellite Healthcare, Inc. |
[Private] |
None, limited coverage |
|
Baxter Healthcare |
BAX |
Home HD product in development, limited coverage |
Inclusion Criteria and Panelist Demographics
|
Inclusion Criteria
|
§ US-based dialysis clinic owners, medical directors and/or managers – nephrologists, RNs § Mix of urban and rural clinics, privately owned and public; geographic distribution § At least 50% of professional time must be spent in the dialysis clinic setting § Must be a key decision maker in purchasing decisions for the clinic § Clinic serves 100 or more end-stage renal disease (ESRD) patients per month, on average § At least moderately familiar with the NxStage System One™ home HD system (at least 5 out of 10 on a scale of 1 to 10, with 1 = not at all familiar; 10 = currently using) § Target 1 to 2 whose clinics have not yet used the system; the remainder should have experience with the system § Target 50% small dialysis clinics and 50% dialysis clinics associated with larger firms (i.e. DaVita, Fresenius, Renal Advantage, Satellite Healthcare / WellBound) |
Hospitals Represented
|
Major Dialysis Company Affiliations |
State |
|
Fresenius |
NJ |
|
None |
NJ |
|
Fresenius |
WA |
|
DaVita, Satellite Healthcare, Wellbound |
CA |
|
None |
PA |
|
DaVita |
MI |
|
DaVita |
NC |
|
None |
NY |
Reports become free one year after the publication date.
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |